CytoMed Therapeutics Limited (GDTC)
Nasdaq: GDTC · Pharmaceutical Preparations · 1 Commonwealth Lane, SG · filing with the SEC since 2021
Who runs CytoMed Therapeutics Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2023
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Goh Yvonne | Chief Financial Officer | May 2026 | May 15, 2026 | none |
| Tan Yoong Ying | Chief Corporate Officer | May 2026 | May 15, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Choo Chee Kong | director | Apr 2023 | Jul 24, 2026 | none |
| Toh Keng Kiat | director | Apr 2023 | May 26, 2026 | none |
| Leong Mark Kei Wei | director | Apr 2023 | May 15, 2026 | none |
| Yew Chak Hua | director | Apr 2023 | May 15, 2026 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.